The Journal of Organic Chemistry
Featured Article
mp 124−126 °C; Rf = 0.71 (hexanes/EtOAc, 20:80); 1H NMR δ 1.53
(s, 9H), 6.89 (d, J = 14.7, 1H), 7.80−7.86 (m, 3H), 7.93−7.95 (m,
2H); 13C NMR δ 28.2, 80.8, 110.7, 124.1, 130.1, 131.4, 135.4, 165.5,
85.8, 87.2, 91.8, 114.3, 118.0, 119.5, 136.2, 139.0, 154.8, 196.8; HRMS
(ESI+) m/z calcd for C23H35N4O6Si+ [M + H]+ 491.2320, found
491.2318.
+
166.3; HRMS (ESI+) m/z calcd for C15H15NNaO4 [M + Na]+
11c (97:3 E:Z, 90 mg, 90%) was obtained using 0.1 equiv of DMAP.
3′,5′-Di-O-acetyl-2′-deoxy-1-[(E)-2-(3-oxo-1-butenyl)vinyl]inosine,
296.0893, found 296.0901.
1
6b (93:7 E:Z, 107 mg, 92%) was obtained using 0.2 equiv of
DABCO. 1-[(E)-2-(tert-Butoxycarbonyl)vinyl]-2-pyridone, (E)-6b:
mp 68−69 °C; Rf = 0.50 (CH2Cl2/MeOH, 96:4); 1H NMR δ 1.52 (s,
9H), 6.05 (d, J = 14.7, 1H), 6.25 (ddd, J = 7.2, J = 6.5, J = 1.2, 1H),
6.59 (dd, J = 9.2, J = 1.2, 1H), 7.34 (ddd, J = 9.3, J = 6.5, J = 1.9, 1H),
7.46 (dd, J = 7.2, J = 1.9, 1H), 8.38 (d, J = 14.7, 1H); 13C NMR δ 28.0,
81.1, 107.3, 110.9, 122.2, 131.6, 137.8, 139.9, 160.9, 164.9; HRMS
(E)-11c: foam; Rf = 0.56 (CH2Cl2/MeOH, 90:10); H NMR δ 2.10
(s, 3H), 2.15 (s, 3H), 2.44 (s, 3H), 2.65 (ddd, J = 6.1, J = 4.2, J = 2.8,
1H), 2.83 (ddd, J = 14.2, J = 7.7, J = 6.5, 1H), 4.31−4.41 (m, 3H),
5.40−5.44 (m, 1H), 6.36 (dd, J = 7.7, J = 6.2, 1H), 6.61 (d, J = 15.1,
1H), 8.00 (s, 1H), 8.23 (s, 1H), 8.33 (d, J = 15.1, 1H); 13C NMR δ
20.7, 20.8, 37.8, 63.5, 74.1, 82.7, 84.6, 119.5, 124.6, 135.9, 138.6, 143.3,
146.3, 154.7, 165.7, 170.1, 170.2, 196.6; HRMS (ESI+) m/z calcd for
+
C18H21N4O7 [M + H]+ 405.1405, found 405.1400.
+
(ESI+) m/z calcd for C12H16NO3 [M + H]+ 222.1125, found
N-Propynoylmorpholine was prepared according to ref 23: 1H
NMR δ 3.19 (s, 1H), 3.62−3.74 (m, 6H), 3.76−3.81 (m, 2H); 13C
NMR δ 41.8, 47.1, 66.3, 66.7, 75.0, 79.7, 151.8.
222.1123.
10b (94:6 E:Z, 118 mg, 91%) was obtained using 0.3 equiv of
DMAP. 1-[(E)-2-(tert-Butoxycarbonyl)vinyl]-5′-O-tert-butyldime-
thylsilyl-2′,3′-O-isopropylideneinosine, (E)-10b: foam; Rf = 0.43
2d (93:7 E:Z, 111 mg, 92%) was obtained using 0.2 equiv of
DABCO. N-[(E)-2-(4-Morpholino)carbonylvinyl]succinimide, (E)-
2d: orange solid; mp 146−148 °C; Rf = 0.64 (hexanes/EtOAc, 20:80);
1H NMR δ 2.82 (s, 4H), 3.70−3.74 (m, 8H), 7.50 (d, J = 14.1, 1H),
7.78 (d, J = 14.1, 1H); 13C NMR δ 27.7, 66.8, 109.0, 130.1, 164.9,
174.6; HRMS (ESI+) m/z calcd for C11H15N2O4+ [M + H]+ 239.1026,
found 239.1034.
1
(hexanes/EtOAc, 60:40); H NMR δ 0.05 (s, 3H), 0.06 (s, 3H), 0.86
(s, 9H), 1.41 (s, 3H), 1.54 (s, 9H), 1.64 (s, 3H), 3.80 (dd, J = 11.4, J =
3.4, 1H), 3.90 (dd, J = 11.4, J = 3.1, 1H), 4.47 (m, 1H), 4.90 (dd, J =
6.1, J = 2.2, 1H), 5.04 (dd, J = 6.1, J = 2.8, 1H), 6.13 (d, J = 2.7, 1H),
6.23 (d, J = 14.6, 1H), 8.09 (s, 1H), 8.19 (s, 1H), 8.30 (d, J = 14.7,
1H); 13C NMR δ −5.6, −5.5, 18.3, 25.3, 25.8, 27.2, 28.1, 63.5, 81.3,
81.7, 85.6, 87.1, 91.6, 113.7, 114.2, 124.5, 136.2, 138.8, 143.5, 146.1,
154.8, 164.4; HRMS (ESI+) m/z calcd for C26H41N4O7Si+ [M + H]+
549.2739, found 549.2738.
(E)-6d (105 mg, 85%) was obtained using 1.0 equiv of DMAP. 1-
[(E)-2-(4-Morpholino)carbonylvinyl]-2-pyridone, (E)-6d: amor-
1
phous; Rf = 0.41 (CH2Cl2/MeOH, 95:5); H NMR δ 3.65 (br s,
(E)-1c (68 mg, 75%) was obtained using 0.2 equiv of DABCO. 1-
[(E)-2-(3-Oxo-1-butenyl)vinyl]-2-pyrrolidinone, (E)-1c:19 oil; Rf =
0.48 (CH2Cl2/MeOH, 95:5); 1H NMR δ 2.16−2.27 (m, 2H), 2.29 (s,
3H), 2.58 (t, J = 8.2, 2H), 3.59 (t, J = 7.2, 2H), 5.54 (d, J = 14.7, 1H),
7.99 (d, J = 14.7, 1H); 13C NMR δ 17.4, 26.5, 31.0, 45.0, 111.4, 137.1,
174.6, 197.8.
8H), 6.20 (ddd, J = 7.1, J = 6.5, J = 1.4, 1H), 6.53 (dd, J = 9.3, J = 1.4,
1H), 7.07 (d, J = 13.9, 1H), 7.26 (ddd, J = 9.3, J = 6.5, J = 1.9, 1H),
7.36 (dd, J = 7.1, J = 1.9. 1H), 8.01 (d, J = 13.9, 1H); 13C NMR δ 42.5,
46.5, 66.8, 107.2, 110.0, 122.6, 134.3, 139.2, 139.4, 162.0, 164.8;
HRMS (ESI+) m/z calcd for C12H15N2O3+ [M + H]+ 235.1077, found
235.1079.
(E)-5c (57 mg, 75%) was obtained using 0.2 equiv of DABCO. (S)-
4-Benzyl-3-[(E)-2-(3-oxo-1-butenyl)vinyl]-1,3-oxazolidin-2-one,
(E)-5c: white solid; mp =108−110 °C; Rf = 0.59 (CH2Cl2/MeOH,
(E)-7d (172 mg, 95%) was obtained using 0.1 equiv of DMAP. 5′-
O-Acetyl-3′-azido-2′-deoxy-1-[(E)-2-morpholinocarbonylvinyl]-
thymidine,24 (E)-7d: white solid; mp 45−47 °C; Rf = 0.50 (CH2Cl2/
1
1
95:5); H NMR δ 2.31 (s, 3H), 2.77−2.87 (m, 1H), 3.21 (m, 1H),
MeOH, 95:5); H NMR δ 1.97 (d, J = 1.1, 3H), 2.14 (s, 3H), 2.38
4.26−4.37 (m, 3H), 5.75 (d, J = 14.9, 1H), 7.16−7.19 (m, 2H), 7.27−
7.39 (m, 3H), 7.80 (d, J = 14.9, 1H); 13C NMR δ 26.7, 36.2, 54.8, 66.9,
111.0, 127.7, 129.1, 129.2, 134.1, 137.3, 154.4, 196.9; IR 3448, 3072,
2963, 1766, 1626, 1416, 1211; HRMS (ESI+) m/z calcd for
(ddd, J = 14.0, J = 7.6, J = 5.6, 1H), 2.55 (ddd, J = 14.0, J = 6.6, J = 5.7,
1H), 3.60 (br s, 2H), 3.71 (br s, 6H), 4.10 (m, 1H), 4.21 (dt, J = 7.6, J
= 5.6, 1H), 4.34 (dd, J = 12.2, J = 3.8, 1H), 4.39 (dd, J = 12.2, J = 4.4,
1H), 6.12 (t, J = 6.1, 1H), 7.30 (q, J = 1.1, 1H), 7.56 (d, J = 14.2, 1H),
8.19 (d, J = 14.2, 1H); 13C NMR δ 13.4, 20.7, 37.8, 42.4 46.2, 60.3,
63.1, 66.8, 82.0, 86.5, 110.1, 112.8, 133.1, 133.4, 149.4, 162.1, 165.4,
170.1; HRMS (ESI+) m/z calcd for C19H25N6O7+ [M + H]+ 449.1779,
found 449.1780.
+
C14H16NO3 [M + H]+ 246.1125, found 246.1118.
(E)-8c (116 mg, 93%) was obtained using 0.1 equiv of DMAP.
2′,3′,5′-Tri-O-acetyl-1-[(E)-2-(3-oxo-1-butenyl)vinyl]inosine, (E)-
1
8c: foam; Rf = 0.57 (CH2Cl2/MeOH, 90:10); H NMR δ 2.11 (s,
3H), 2.14 (s, 3H), 2.15 (s, 3H), 2.43 (s, 3H), 4.34−4.48 (m, 3H), 5.56
(t, J = 5.1, 1H), 5.85 (t, J = 5.3, 1H), 6.10 (d, J = 5.1, 1H) 6.61 (d, J =
15.1, 1H), 7.98 (s, 1H), 8.24 (s, 1H), 8.31 (d, J = 15.2, 1H); 13C NMR
δ 20.3, 20.4, 20.7, 27.8, 62.9, 70.3, 73.3, 80.3, 86.6, 119.7, 124.8, 136.9,
139.0, 143.5, 146.4, 154.7, 169.2, 169.5, 170.2, 196.6; HRMS (ESI+)
N-Methoxy-N-methylpropynamide was prepared according to ref
23: H NMR δ 3.11 (s, 1H), 3.24 (br s, 3H), 3.78 (s, 3H).
1
(E)-6e (93 mg, 85%) was obtained using 0.1 equiv of DMAP. 1-
[(E)-2-(N-Methoxy-N-methylaminocarbonyl)vinyl]-2-pyridone,
(E)-6e: white solid; mp 110−111 °C; Rf = 0.40 (CH2Cl2/MeOH,
+
m/z calcd for C20H23N4O9 [M + H]+ 463.1460, found 463.1457.
1
95:5); H NMR δ 3.23 (s, 3H), 3.69 (s, 3H), 6.20 (ddd, J = 7.2, 6.6,
9c (93:7 E:Z, 101 mg, 97%) was obtained using 0.1 equiv of DMAP.
5′-O-Acetyl-2′,3′-O-isopropylidene-1-[(E)-2-(3-oxo-1-butenyl)-
vinyl]inosine, (E)-9c: white solid; mp 151−153 °C; Rf = 0.52
(CH2Cl2/MeOH, 90:10); 1H NMR δ 1.40 (s, 3H), 1.64 (s, 3H), 2.04
(s, 3H), 2.44 (s, 3H), 4.25 (dd, J = 12.0, J = 5.6, 1H), 4.35 (dd, J =
12.0, J = 4.2, 1H), 4.51−4.54 (m, 1H), 4.94 (dd, J = 6.3, J = 3.4, 1H),
5.22 (dd, J = 6.3, J = 2.4, 1H), 6.11 (d, J = 2.4, 1H), 6.61 (d, J = 15.1,
1H), 7.93 (s, 1H), 8.25 (s, 1H), 8.32 (d, J = 15.2, 1H); 13C NMR δ
20.7, 25.3, 27.1, 27.8, 63.9, 81.3, 84.6, 84.8, 91.0, 115.0, 119.6, 124.9,
135.9, 139.3, 140.0, 143.4, 154.7, 170.3, 196.6; HRMS (ESI+) m/z
1.3, 1H), 6.53 (dd, J = 9.0, J = 1.3, 1H), 6.84 (d, J = 14.4, 1H), 7.27
(ddd, J = 9.0, 6.6, 2.1, 1H), 7.44 (dd, J = 7.2, 1.9, 1H), 8.31 (d, J =
14.4, 1H); 13C NMR δ 32.3, 61.8, 107.1, 107.5, 122.3, 132.5, 138.6,
139.6, 161.2, 165.7; HRMS (ESI+) m/z calcd for C10H13N2O3+ [M +
H]+ 209.0921, found 209.0918.
(E)-7e (126 mg, 90%) was obtained using 0.1 equiv of DMAP. 5′-
O-Acetyl-3′-azido-3′-deoxy-3-[(E)-2-(N-methoxy-N-
methylaminocarbonylvinyl]thymidine,25 (E)-7e: white solid; mp
111−113 °C; Rf = 0.44 (CH2Cl2/MeOH, 95:5); 1H NMR δ 1.98 (d, J
= 1.2, 3H), 2.14 (s, 3H), 2.40 (ddd, J = 14.1, J = 7.6, J = 5.6, 1H) 1H),
2.53 (ddd, J = 14.1, J = 6.7, J = 5.6, 1H), 3.28 (s, 3H), 3.75 (s, 3H),
4.10 (dt, J = 5.6, J = 4.1, 1H), 4.21 (dt, J = 7.6, J = 5.6, 1H), 4.34 (dd, J
= 12.2, J = 3.8, 1H), 4.39 (dd, J = 12.2, J = 4.4, 1H), 6.14 (t, J = 6.2,
1H), 7.30 (q, J = 1.2, 1H), 7.60 (d, J = 14.6, 1H), 8.21 (d, J = 14.6,
1H); 13C NMR δ 13.5, 20.7, 32.5, 37.8, 60.3, 61.8, 63.1, 81.9, 86.5,
110.1, 112.1, 133.4, 133.4, 149.3, 162.0, 167.0, 170.1; HRMS (ESI+)
+
calcd for C19H23N4O7 [M + H]+ 419.1561, found 419.1555.
10c (91:9 E:Z, 95 mg, 97%) was obtained using 0.1 equiv of DMAP.
5′-O-tert-Butyldimethylsilyl-2′,3′-O-isopropylidene-1-[(E)-2-(3-
oxo-1-butenyl)vinyl]inosine, (E)-10c: foam; Rf = 0.56 (CH2Cl2/
1
MeOH, 90:10); H NMR δ 0.06 (s, 3H), 0.05 (s, 3H), 0.86 (s, 9H),
1.41 (s, 3H), 1.64 (s, 3H), 2.43 (s, 3H), 3.81 (dd, 1H, J = 11.4, J =
3.3), 3.91 (dd, 1H, J = 11.4, J = 3.0), 4.46−4.49 (m, 1H), 4.90 (dd, 1H,
J = 6.1, J = 2.2), 5.03 (dd, 1H, J = 6.1, J = 2.8), 6.14 (d, 1H, J = 2.8),
6.57 (d, 1H, J = 15.1), 8.11 (s, 1H), 8.24 (s, 1H), 8.35 (d, 1H, J =
15.1); 13C NMR δ −5.6, −5.4, 18.3, 25.3, 25.9, 27.2, 27.2, 63.6, 81.3,
+
m/z calcd for C17H23N6O7 [M + H]+ 423.1623, found 423.1619.
8e (91:9 E:Z, 53 mg, 80%) was obtained using 0.2 equiv of
DABCO. 2′,3′,5′-Tri-O-acetyl-1-[(E)-2-(N-methoxy-N-
methylaminocarbonyl)vinyl]inosine, (E)-8e: foam; Rf = 0.68
H
dx.doi.org/10.1021/jo4006409 | J. Org. Chem. XXXX, XXX, XXX−XXX